
Cementless Total Knee Systems Market Report 2026
Global Outlook – By Component (Tibial Component, Femoral Component), By Fixation Method (Primary Fixation, Hybrid Fixation), By End User (Hospitals, Orthopedic Centers, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Cementless Total Knee Systems Market Overview
• Cementless Total Knee Systems market size has reached to $4.68 billion in 2025 • Expected to grow to $6.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.2% • Growth Driver: Rising Prevalence Of Orthopedic Conditions Fueling The Growth Of The Market Due To Increasing Demand For Durable Joint Replacement Solutions • Market Trend: Advancements In Technology And Personalization Enhancing Knee Implant Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Cementless Total Knee Systems Market?
Cementless total knee system refers to a type of knee implant designed to achieve fixation without bone cement, relying instead on bone growth into the implant for long-term stability. It is utilized during total knee replacement surgery to replace damaged joint surfaces, allowing natural bone to grow into the implant for secure fixation without the use of bone cement. The main components of the cementless total knee systems are tibial components and femoral components. Tibial components are parts of a knee replacement system that are implanted into the top of the shinbone to provide a stable base for the artificial knee joint. Multiple fixation methods are primary fixation and hybrid fixation, and they are used by several end users, such as hospitals, orthopedic centers, and others.
What Is The Cementless Total Knee Systems Market Size and Share 2026?
The cementless total knee systems market size has grown strongly in recent years. It will grow from $4.68 billion in 2025 to $4.94 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to limited availability of cementless implants, reliance on traditional cemented knee systems, growing geriatric population with osteoarthritis, increasing hospital orthopedic surgeries, rising awareness about knee replacement benefits.What Is The Cementless Total Knee Systems Market Growth Forecast?
The cementless total knee systems market size is expected to see strong growth in the next few years. It will grow to $6.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to advancement in 3d-printing and porous coating technologies, growing preference for minimally invasive surgeries, expansion of orthopedic healthcare infrastructure, increasing adoption of robotic-assisted knee replacement, rising investment in patient-specific knee implants. Major trends in the forecast period include rising adoption of cementless knee implants, increased use of porous-coated and 3d-printed components, expansion of orthopedic centers and specialized hospitals, focus on minimally invasive knee replacement procedures, enhanced post-operative recovery and patient outcomes.Global Cementless Total Knee Systems Market Segmentation
1) By Component: Tibial Component, Femoral Component 2) By Fixation Method: Primary Fixation, Hybrid Fixation 3) By End User: Hospitals, Orthopedic Centers, Other End Users Subsegments: 1) By Tibial Component: Fixed-Bearing Tibial Baseplates, Mobile-Bearing Tibial Baseplates, Modular Tibial Components, Monoblock Tibial Components, Porous-Coated Tibial Components, 3D-Printed Tibial Components 2) By Femoral Component: Posterior-Stabilized Femoral Components, Cruciate-Retaining Femoral Components, Ultra-Congruent Femoral Components, Asymmetric Femoral Components, Anatomical Femoral Components, Cementless Porous-Coated Femoral ComponentsWhat Is The Driver Of The Cementless Total Knee Systems Market?
The increasing prevalence of orthopedic diseases is expected to propel the growth of the cementless total knee systems market going forward. Orthopedic diseases are conditions that affect the musculoskeletal system, including bones, joints, muscles, ligaments, and tendons, leading to pain, reduced mobility, and functional impairment. The rising prevalence of orthopedic diseases is due to aging populations seeking long-term mobility solutions that reduce joint pain, enhance movement, and support an active lifestyle with minimal medical intervention. Cementless total knee systems provide a durable and biologically integrated solution for orthopedic diseases by encouraging natural bone growth, minimizing implant loosening, and restoring joint function without the use of bone cement. For instance, in January 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, the percentage of those 16 and older who self-reported having a long-term musculoskeletal (MSK) disease, a type of orthopedic disease, increased from 17.6% in 2022 to 18.4% in 2023. Therefore, the increasing prevalence of orthopedic diseases is driving the growth of the cementless total knee systems industry.Key Players In The Global Cementless Total Knee Systems Market
Major companies operating in the cementless total knee systems market are Johnson And Johnson Services Inc, Stryker Corporation, Zimmer Biomet Holdings Inc, Smith And Nephew plc, Enovis Corporation, MicroPort Scientific Corporation, Medacta International SA, B Braun Melsungen AG, Waldemar Link GmbH And Co KG, restor3d Inc, implantcast GmbH, United Orthopedic Corporation, Signature Orthopaedics Pty Ltd, Gruppo Bioimpianti Srl, Permedica SPA, Evolutis SAS, Euromed Implants GmbH, X NOV SAS, Beijing Chunli Zhongke Bio Tech Co Ltd, Exactech Inc, Corin Group, LimaCorporate SPAGlobal Cementless Total Knee Systems Market Trends and Insights
Major companies operating in the cementless total knee systems market are focusing on developing advanced technologies, such as TIDAL technology, to deliver advanced porous implants that enhance bone integration and implant durability. TIDAL technology is an advanced 3D-printed porous implant design that optimizes bone integration by enhancing mechanical strength, fatigue resistance, and load distribution for long-lasting implant stability. For instance, in April 2025, Restor3D Inc., a US-based medical device company, received Food and Drug Administration (FDA) 510(k) clearance for the iTotal Identity CR 3DP porous total knee system, its first cementless patient-specific implant. This innovative system leverages advanced 3D printing and porous technology to provide enhanced bone integration and stability, while its personalized design, custom surgical instruments, and pre-navigated surgical approach help surgeons achieve higher accuracy and efficiency.What Are Latest Mergers And Acquisitions In The Cementless Total Knee Systems Market?
In September 2023, Restor3D Inc., a US-based medical device company, acquired ConforMIS Inc. for an undisclosed amount. Through this acquisition, Restor3D aims to expand its portfolio of patient-specific orthopedic implants by integrating Conformis’ expertise in personalized knee replacement technology and accelerating innovation in 3D-printed cementless implant solutions. ConforMIS Inc. is a US-based medical technology company specializing in total knee implants designed for cementless fixation.Regional Outlook
North America was the largest region in the cementless total knee systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Cementless Total Knee Systems Market?
The cementless total knee systems market consists of sales of cruciate-retaining designs, mobile-bearing systems, cobalt-chromium alloys, patellar components, polyethylene inserts, and porous-coated implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Cementless Total Knee Systems Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.94 billion |
| Revenue Forecast In 2035 | $6.06 billion |
| Growth Rate | CAGR of 5.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component, Fixation Method, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Johnson And Johnson Services Inc, Stryker Corporation, Zimmer Biomet Holdings Inc, Smith And Nephew plc, Enovis Corporation, MicroPort Scientific Corporation, Medacta International SA, B Braun Melsungen AG, Waldemar Link GmbH And Co KG, restor3d Inc, implantcast GmbH, United Orthopedic Corporation, Signature Orthopaedics Pty Ltd, Gruppo Bioimpianti Srl, Permedica SPA, Evolutis SAS, Euromed Implants GmbH, X NOV SAS, Beijing Chunli Zhongke Bio Tech Co Ltd, Exactech Inc, Corin Group, LimaCorporate SPA |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
